Completed PHASE1 INTERVENTIONAL 5-arm NCT02599792

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

A Two-Part Phase 1 Healthy Volunteer Study: A Crossover Comparison of CTP-656 Solid Dose Formulation vs. Kalydeco® and a Double-Blind, Placebo-Controlled, Ascending Multiple Dose Evaluation of CTP-656

Sponsor: Concert Pharmaceuticals

Conditions Healthy

Interventions CTP-656 Kalydeco Placebo for CTP-656

Updated 5 times since 2017 Last updated: Apr 29, 2016 Started: Nov 30, 2015 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Concert Pharmaceuticals and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Concert Pharmaceuticals

Data source: Concert Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Adelaide, Australia